Northwest Bio allegations prompt top U.K. investor to call for independent probe

Neil Woodford has invested $95 million in Northwest Biotherapeutics ($NWBO) and its controversial therapeutic cancer vaccine over the past year. And now that he has bought up 28% of the company's stock, he's pushing hard for an independent investigation into allegations of financial impropriety that have been in circulation since before he took his first big stake in the biotech. More from FierceBiotech